Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Jilma

Showing results (1-10 of 468) with videos related to

Pageof 47
Sort By:
Thrombosis and Haemostasis|November 16, 2004
The Thr715Pro single nucleotide polymorphism of P-selectin: does it really matter in cardiovascular or thrombotic disorders?Bernd Jilma
Thrombosis and Haemostasis|May 6, 2006
Antithrombin for severe sepsis? Try it again, but without heparin!Bernd Jilma
Wiener Medizinische Wochenschrift (1946)|December 3, 2003
"Advances in thrombosis and haemostasis"Bernd Jilma
Journal of the American College of Cardiology|April 6, 2004
Therapeutic failure or resistance to aspirinBernd Jilma
Intensive Care Medicine|February 16, 2005
Safety of endotoxin challenge in healthy volunteers: bradycardiaBernd Jilma
Stroke|April 12, 2003
Synergistic antiplatelet effects of clopidogrel and aspirin detected with the PFA-100 in stroke patientsBernd Jilma
Drug Discovery Today|May 23, 2025
Effectiveness of histamine receptor antagonists in the treatment of histamine-driven clinical symptoms: do we have a histamine or, better, an anti-histamine problem?Thomas Boehm, Bernd Jilma
JACC. Cardiovascular Interventions|August 5, 2019
Methylnaltrexone to Reduce the Inhibitory Effects of Opioids on Drug AbsorptionChristian Schoergenhofer, Bernd Jilma
Expert Review of Clinical Pharmacology|September 6, 2022
Clinical pharmacology of antiplatelet drugsGeorg Gelbenegger, Bernd Jilma
Drug Discovery Today|June 18, 2026
Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxisThomas Boehm, Bernd Jilma
Pageof 47

Showing results (1-10 of 468) with videos related to

Sort By:
Pageof 47
Thrombosis and Haemostasis|November 16, 2004
The Thr715Pro single nucleotide polymorphism of P-selectin: does it really matter in cardiovascular or thrombotic disorders?Bernd Jilma
Thrombosis and Haemostasis|May 6, 2006
Antithrombin for severe sepsis? Try it again, but without heparin!Bernd Jilma
Wiener Medizinische Wochenschrift (1946)|December 3, 2003
"Advances in thrombosis and haemostasis"Bernd Jilma
Journal of the American College of Cardiology|April 6, 2004
Therapeutic failure or resistance to aspirinBernd Jilma
Intensive Care Medicine|February 16, 2005
Safety of endotoxin challenge in healthy volunteers: bradycardiaBernd Jilma
Stroke|April 12, 2003
Synergistic antiplatelet effects of clopidogrel and aspirin detected with the PFA-100 in stroke patientsBernd Jilma
Drug Discovery Today|May 23, 2025
Effectiveness of histamine receptor antagonists in the treatment of histamine-driven clinical symptoms: do we have a histamine or, better, an anti-histamine problem?Thomas Boehm, Bernd Jilma
JACC. Cardiovascular Interventions|August 5, 2019
Methylnaltrexone to Reduce the Inhibitory Effects of Opioids on Drug AbsorptionChristian Schoergenhofer, Bernd Jilma
Expert Review of Clinical Pharmacology|September 6, 2022
Clinical pharmacology of antiplatelet drugsGeorg Gelbenegger, Bernd Jilma
Drug Discovery Today|June 18, 2026
Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxisThomas Boehm, Bernd Jilma
Pageof 47